Cargando…

Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma

Immunohistochemically determined Ki-67 scores and flow cytometrically determined S-phase fractions were successfully evaluated from the primary tumours of 123 patients with soft-tissue sarcoma. All patients had either limb or superficial trunk tumours. Ki-67 score correlated strongly with ploidy, S-...

Descripción completa

Detalles Bibliográficos
Autores principales: Huuhtanen, R L, Blomqvist, C P, Wiklund, T A, Böhling, T O, Virolainen, M J, Tukiainen, E J, Tribukait, B, Andersson, L C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362649/
https://www.ncbi.nlm.nih.gov/pubmed/10070895
http://dx.doi.org/10.1038/sj.bjc.6690151
_version_ 1782153505591525376
author Huuhtanen, R L
Blomqvist, C P
Wiklund, T A
Böhling, T O
Virolainen, M J
Tukiainen, E J
Tribukait, B
Andersson, L C
author_facet Huuhtanen, R L
Blomqvist, C P
Wiklund, T A
Böhling, T O
Virolainen, M J
Tukiainen, E J
Tribukait, B
Andersson, L C
author_sort Huuhtanen, R L
collection PubMed
description Immunohistochemically determined Ki-67 scores and flow cytometrically determined S-phase fractions were successfully evaluated from the primary tumours of 123 patients with soft-tissue sarcoma. All patients had either limb or superficial trunk tumours. Ki-67 score correlated strongly with ploidy, S-phase fraction and grade. Ki-67 did not correlate with the size of the primary tumour. When analysed as a continuous variable, Ki-67 was a stronger predictor of both metastasis-free survival and disease-specific overall survival (P= 0.003 and 0.04 respectively) than was the S-phase fraction (P= 0.06 and 0.07 respectively). We tested the relevance of different cut-point values by dividing the whole material into two parts at every 10% (e.g. 10% of patients vs. the remaining 90%, 20% vs. 80%, etc.). We counted the relative risk and confidence interval at all these cut-off points. Ki-67 had good prognostic discriminating power irrespective of the cut-point value, but S-phase fraction lost its prognostic power at higher cut-point values. In conclusion, we found that Ki-67 is a useful prognostic tool in the treatment of soft-tissue sarcoma patients irrespective of the cut-point value. S-phase fraction can be used at lower cut-point values. © 1999 Cancer Research Campaign
format Text
id pubmed-2362649
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23626492009-09-10 Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma Huuhtanen, R L Blomqvist, C P Wiklund, T A Böhling, T O Virolainen, M J Tukiainen, E J Tribukait, B Andersson, L C Br J Cancer Regular Article Immunohistochemically determined Ki-67 scores and flow cytometrically determined S-phase fractions were successfully evaluated from the primary tumours of 123 patients with soft-tissue sarcoma. All patients had either limb or superficial trunk tumours. Ki-67 score correlated strongly with ploidy, S-phase fraction and grade. Ki-67 did not correlate with the size of the primary tumour. When analysed as a continuous variable, Ki-67 was a stronger predictor of both metastasis-free survival and disease-specific overall survival (P= 0.003 and 0.04 respectively) than was the S-phase fraction (P= 0.06 and 0.07 respectively). We tested the relevance of different cut-point values by dividing the whole material into two parts at every 10% (e.g. 10% of patients vs. the remaining 90%, 20% vs. 80%, etc.). We counted the relative risk and confidence interval at all these cut-off points. Ki-67 had good prognostic discriminating power irrespective of the cut-point value, but S-phase fraction lost its prognostic power at higher cut-point values. In conclusion, we found that Ki-67 is a useful prognostic tool in the treatment of soft-tissue sarcoma patients irrespective of the cut-point value. S-phase fraction can be used at lower cut-point values. © 1999 Cancer Research Campaign Nature Publishing Group 1999-02 /pmc/articles/PMC2362649/ /pubmed/10070895 http://dx.doi.org/10.1038/sj.bjc.6690151 Text en Copyright © 1999 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Huuhtanen, R L
Blomqvist, C P
Wiklund, T A
Böhling, T O
Virolainen, M J
Tukiainen, E J
Tribukait, B
Andersson, L C
Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
title Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
title_full Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
title_fullStr Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
title_full_unstemmed Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
title_short Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
title_sort comparison of the ki-67 score and s-phase fraction as prognostic variables in soft-tissue sarcoma
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362649/
https://www.ncbi.nlm.nih.gov/pubmed/10070895
http://dx.doi.org/10.1038/sj.bjc.6690151
work_keys_str_mv AT huuhtanenrl comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT blomqvistcp comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT wiklundta comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT bohlingto comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT virolainenmj comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT tukiainenej comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT tribukaitb comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma
AT anderssonlc comparisonoftheki67scoreandsphasefractionasprognosticvariablesinsofttissuesarcoma